Evidence map›Paper›PMID 39269276›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Biochemically Programmable Isothermal PCR.

MinGin Kim, Vijay Ravisankar, Yassin A Hassan, Victor M Ugaz

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Biochemically Programmable Isothermal PCR.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

MinGin KimArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA.
Vijay RavisankarArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA.
Yassin A HassanDepartment of Nuclear Engineering, Texas A&M University, College Station, TX, 77843, USA.
Victor M UgazArtie McFerrin Department of Chemical Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0001-9361-9950

Funding

Directorate for Engineering 1807441National Institute for Innovation in Manufacturing Biopharmaceuticals 70NANB21H085W. M. Keck Foundation
6 · The paper itself

Abstract

Isothermal PCR can be performed by imposing a static temperature gradient that continuously circulates reagents through denaturing, annealing, and extension conditions inside a PCR tube. But despite early promise, these systems have yet to demonstrate performance and repeatability sufficient for adoption in validated laboratory tests because the rate-limiting extension step is inherently short and cannot be increased independently of the other stages in a temperature cycle. Here, a discovery that enables isothermal PCR to be achieved with statistically robust repeatability that meets or exceeds diagnostic assay requirements (false positive/negative rate <8% at 95% confidence) by manipulating the interplay between the DNA replication biochemistry (via the amplicon GC content) and the microscale circulatory flow inside a PCR tube is reported. Surprisingly, optimal performance depends on selecting primer sequences that replicate high GC content amplicons, contradicting established PCR primer design rules. This innovative thermocycling approach accelerates PCR to speeds rivaling ultra-fast instruments, enabling rapid, repeatable isothermal DNA analysis across a range of targets relevant to diagnostics and pathogen detection.

Indexed as

Polymerase Chain ReactionDNADNA PrimersReproducibility of ResultsTemperatureDNADNA Primersbiochemistrynucleic acid analysisPCRpoint of care diagnostics

Identifiers

PMID39269276
PMCPMC11538674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.